⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TPST News
Tempest Therapeutics, Inc. Common Stock
Tempest to Present at the H.C. Wainwright 28th Annual Global Investment Conference
globenewswire.com
TPST
Form 8-K
sec.gov
TPST
RNAZ
Form 8-K
sec.gov
TPST
Form 8-K
sec.gov
TPST
Form 8-K
sec.gov
TPST
Tempest Reports Second Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
TPST
Form 8-K
sec.gov
TPST
Form 8-K
sec.gov
TPST
Tempest Announces Development Collaboration with Senlang Biotechnology for TPST-4003, a CD7-Targeted Next-Generation In Vivo CAR-T
globenewswire.com
TPST
Tempest Unveils Next-Generation In Vivo CAR-T Pipeline, with First Clinical Study Planned for the Fourth Quarter of 2026
globenewswire.com
TPST